Membranous nephropathy is developed under Th2 environment in chronic graft-versus-host disease

被引:11
作者
Nakashima, Hitoshi [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan
关键词
D O I
10.1016/j.mehy.2007.02.015
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Clinical data from case reports of nephrotic syndrome including allogenetic hematopoietic stem cell transplantation (HSCT) suggest that there may be some relationship between chronic graft-versus -host disease (GVHD) and membranous nephropathy (MIN). It is widely recognized T cells are crucial for the development of GVHD, and that T helper (Th) cells differentiate into at least two subsets, Th1 and Th2. The polarized situation between Th1 and Th2 cells is established to be important in animal models and human autoimmune diseases. In a chronic GVHD murine model a Th2 cell plays a pivotal role for the pathogenesis. In MRL/Ipr mice, which is particularly valuable model for systemic lupus erythematosus, developed diffuse proliferative glomerutonephritis (DPGN) in Thl environment and MN in Th2 environment. Similarly, Th2 cells may be predominantly activated in chronic GVHD, production and deposition of IgG4 in the glomeruti may develop MN. A hypothesis is: when the patient in period of chronic GVHD developed immune complex-mediated disease, IgG4 might be mainly produced in Th2 environment, and the deposition of IgG4 in the glomeruti may result in the formation of MN. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:787 / 791
页数:5
相关论文
共 50 条
[1]  
AGODOA LYC, 1985, J IMMUNOL, V134, P880
[2]  
Akar H, 2002, J NEPHROL, V15, P79
[3]   Cutaneous graft-versus-host disease [J].
Aractingi, S ;
Chosidow, O .
ARCHIVES OF DERMATOLOGY, 1998, 134 (05) :602-612
[4]   The role of IL-4 and IL-12 in the regulation of collagen synthesis by fibroblasts [J].
Banning, Ursula ;
Krutmann, Jean ;
Koerholz, Dieter .
IMMUNOLOGICAL INVESTIGATIONS, 2006, 35 (02) :199-207
[5]  
BARBARA JAJ, 1992, CLIN NEPHROL, V37, P115
[6]  
BLAZAR BR, 1993, J IMMUNOL, V150, P265
[7]  
BRUIJN JA, 1988, AM J PATHOL, V130, P639
[8]  
DEVEY ME, 1985, IMMUNOLOGY, V55, P565
[9]  
DOI T, 1984, CLIN EXP IMMUNOL, V58, P57
[10]  
Ehrenreich T., 1968, PATHOL ANNU, V3, P145